Status:
ACTIVE_NOT_RECRUITING
International Alfapump Cohort Study
Lead Sponsor:
Sequana Medical N.V.
Conditions:
Liver Cirrhoses
Malignant Ascites
Eligibility:
All Genders
Brief Summary
This Registry is designed to follow patients who have been implanted with an alfapump system, which is a newly marketed product from Sequana Medical AG, a Swiss Medical Device company.
Detailed Description
In a real-world setting, all patients implanted with an alfapump system according to it's intended use, not participating in another clinical study in which the alfapump is studied.
Eligibility Criteria
Inclusion
- All patients implanted with an alfapump are eligible for this registry
Exclusion
- Patients younger than 18 years
- Pregnancy
- Inability to operate the Smart Charger to recharge the alfapump
- Participating in another study in which the alfapump is studied
Key Trial Info
Start Date :
August 14 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04326946
Start Date
August 14 2018
End Date
December 31 2030
Last Update
November 12 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsklinikum Leipzig
Leipzig, Germany, 04103
2
Inselspital
Bern, Switzerland, 3010